PURPOSE: We determined whether pelvic soft tissue and bony dimensions on endorectal magnetic resonance imaging influence the recovery of continence after radical prostatectomy, and whether adding significant magnetic resonance imaging variables to a statistical model improves the prediction of continence recovery. MATERIALS AND METHODS: Between 2001 and 2004, 967 men undergoing radical prostatectomy underwent preoperative magnetic resonance imaging. Soft tissue and bony dimensions were retrospectively measured by 2 raters blinded to clinical and pathological data. Patients who received neoadjuvant therapy, who were preoperatively incontinent or had missing followup for continence were excluded from study, leaving 600 patients eligible for analysis. No pad use defined continent. Logistic regression was used to identify variables associated with continence recovery at 6 and 12 months. We evaluated whether the predictive accuracy of a base model was improved by adding independently significant magnetic resonance imaging variables. RESULTS: Urethral length and urethral volume were significantly associated with the recovery of continence at 6 and 12 months. Larger inner and outer levator distances were significantly associated with a decreased probability of regaining continence at 6 or 12 months, but they did not reach statistical significance for other points. Addition of these 4 magnetic resonance imaging variables to a base model including age, clinical stage, prostate specific antigen and comorbidities marginally improved the discrimination (12-month AUC improved from 0.587 to 0.634). CONCLUSIONS: Membranous urethral length, urethral volume, and an anatomically close relation between the levator muscle and membranous urethra on preoperative magnetic resonance imaging are independent predictors of continence recovery after radical prostatectomy. The addition of magnetic resonance imaging variables to a base model improved the predictive accuracy for continence recovery, but the predictive accuracy remains low.
PURPOSE: We determined whether pelvic soft tissue and bony dimensions on endorectal magnetic resonance imaging influence the recovery of continence after radical prostatectomy, and whether adding significant magnetic resonance imaging variables to a statistical model improves the prediction of continence recovery. MATERIALS AND METHODS: Between 2001 and 2004, 967 men undergoing radical prostatectomy underwent preoperative magnetic resonance imaging. Soft tissue and bony dimensions were retrospectively measured by 2 raters blinded to clinical and pathological data. Patients who received neoadjuvant therapy, who were preoperatively incontinent or had missing followup for continence were excluded from study, leaving 600 patients eligible for analysis. No pad use defined continent. Logistic regression was used to identify variables associated with continence recovery at 6 and 12 months. We evaluated whether the predictive accuracy of a base model was improved by adding independently significant magnetic resonance imaging variables. RESULTS: Urethral length and urethral volume were significantly associated with the recovery of continence at 6 and 12 months. Larger inner and outer levator distances were significantly associated with a decreased probability of regaining continence at 6 or 12 months, but they did not reach statistical significance for other points. Addition of these 4 magnetic resonance imaging variables to a base model including age, clinical stage, prostate specific antigen and comorbidities marginally improved the discrimination (12-month AUC improved from 0.587 to 0.634). CONCLUSIONS: Membranous urethral length, urethral volume, and an anatomically close relation between the levator muscle and membranous urethra on preoperative magnetic resonance imaging are independent predictors of continence recovery after radical prostatectomy. The addition of magnetic resonance imaging variables to a base model improved the predictive accuracy for continence recovery, but the predictive accuracy remains low.
Authors: David F Penson; Dale McLerran; Ziding Feng; Lin Li; Peter C Albertsen; Frank D Gilliland; Ann Hamilton; Richard M Hoffman; Robert A Stephenson; Arnold L Potosky; Janet L Stanford Journal: J Urol Date: 2005-05 Impact factor: 7.450
Authors: Mika P Matikainen; Christian J von Bodman; Fernando P Secin; Luis Herran Yunis; Kinjal Vora; Bertrand Guillonneau; Vincent Laudone; James A Eastham; Peter T Scardino; Oguz Akin; Farhang Rabbani Journal: BJU Int Date: 2010-09 Impact factor: 5.588
Authors: Lars Budäus; Hendrik Isbarn; Thorsten Schlomm; Hans Heinzer; Alexander Haese; Thomas Steuber; Georg Salomon; Hartwig Huland; Markus Graefen Journal: Eur Urol Date: 2009-05-29 Impact factor: 20.096
Authors: Antonio Tienza; Mateo Hevia; Alberto Benito; Juan I Pascual; Juan Javier Zudaire; Jose Enrique Robles Journal: Int Urol Nephrol Date: 2015-06-07 Impact factor: 2.370
Authors: Irina Soljanik; Ricarda M Bauer; Armin J Becker; Christian G Stief; Christian Gozzi; Olga Solyanik; Kerstin A Brocker; Sonja M Kirchhoff Journal: World J Urol Date: 2014-01-23 Impact factor: 4.226
Authors: Anne P Cameron; Anne M Suskind; Charlene Neer; Hero Hussain; Jeffrey Montgomery; Jerilyn M Latini; John O DeLancey Journal: Neurourol Urodyn Date: 2014-04-21 Impact factor: 2.696
Authors: Chiara Marigliano; Olivio F Donati; Hebert Alberto Vargas; Oguz Akin; Debra A Goldman; James A Eastham; Michael J Zelefsky; Hedvig Hricak Journal: Eur J Radiol Date: 2013-09-22 Impact factor: 3.528
Authors: Kazuhito Matsushita; Matthew T Kent; Andrew J Vickers; Christian von Bodman; Melanie Bernstein; Karim A Touijer; Jonathan A Coleman; Vincent T Laudone; Peter T Scardino; James A Eastham; Oguz Akin; Jaspreet S Sandhu Journal: BJU Int Date: 2015-03-30 Impact factor: 5.588
Authors: M E O'Callaghan; E Raymond; J Campbell; A D Vincent; K Beckmann; D Roder; S Evans; J McNeil; J Millar; J Zalcberg; M Borg; K Moretti Journal: Prostate Cancer Prostatic Dis Date: 2017-06-06 Impact factor: 5.554